Patents by Inventor Peter Tasko

Peter Tasko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8858984
    Abstract: A lozenge is provided that has stable pH and stable levels of active ingredient over time. It comprises a combination of (i) at least one gum and (ii) at least one non-crystallizing sugar or non-crystallizing sugar alcohol in a matrix designed for controlled buccal delivery of a drug. The lozenge also contains water and optional components selected from flavorings, taste masking agents, colorings, buffer components, pH adjusting agents, excipients, stabilizers and sweeteners. Methods of preparing the lozenge are also provided.
    Type: Grant
    Filed: November 5, 2013
    Date of Patent: October 14, 2014
    Assignee: Gelmedic Holding ApS
    Inventors: Anders Dam, Janos Major, Peter Tasko
  • Publication number: 20140054826
    Abstract: A lozenge is provided that has stable pH and stable levels of active ingredient over time. It comprises a combination of (i) at least one gum and (ii) at least one non-crystallising sugar or non-crystallising sugar alcohol in a matrix designed for controlled buccal delivery of a drug. The lozenge also contains water and optional components selected from flavourings, taste masking agents, colourings, buffer components, pH adjusting agents, excipients, stabilizers and sweeteners. Methods of preparing the lozenge are also provided.
    Type: Application
    Filed: November 5, 2013
    Publication date: February 27, 2014
    Applicant: Gelmedic Holding AG
    Inventors: Anders Dam, Janos Major, Peter Tasko
  • Patent number: 8603517
    Abstract: A lozenge is provided that has stable pH and stable levels of active ingredient over time. It comprises a combination of (i) at least one gum and (ii) at least one non-crystallising sugar or non-crystallising sugar alcohol in a matrix designed for controlled buccal delivery of a drug. The lozenge also contains water and optional components selected from flavorings, taste masking agents, colorings, buffer components, pH adjusting agents, excipients, stabilizers and sweeteners. Methods of preparing the lozenge are also provided.
    Type: Grant
    Filed: November 28, 2012
    Date of Patent: December 10, 2013
    Assignee: Gelmedic Holdings APS
    Inventors: Anders Dam, Janos Major, Peter Tasko
  • Patent number: 8603516
    Abstract: A lozenge is provided that has stable pH and stable levels of active ingredient over time. It comprises a combination of (i) at least one gum and (ii) at least one non-crystallising sugar or non-crystallising sugar alcohol in a matrix designed for controlled buccal delivery of a drug. The lozenge also contains water and optional components selected from flavorings, taste masking agents, colorings, buffer components, pH adjusting agents, excipients, stabilizers and sweeteners. Methods of preparing the lozenge are also provided.
    Type: Grant
    Filed: November 26, 2012
    Date of Patent: December 10, 2013
    Assignee: Gelmedic Holding APS
    Inventors: Anders Dam, Janos Major, Peter Tasko
  • Publication number: 20130087946
    Abstract: A lozenge is provided that has stable pH and stable levels of active ingredient over time. It comprises a combination of (i) at least one gum and (ii) at least one non-crystallising sugar or non-crystallising sugar alcohol in a matrix designed for controlled buccal delivery of a drug. The lozenge also contains water and optional components selected from flavourings, taste masking agents, colourings, buffer components, pH adjusting agents, excipients, stabilizers and sweeteners. Methods of preparing the lozenge are also provided.
    Type: Application
    Filed: November 28, 2012
    Publication date: April 11, 2013
    Applicant: Arrow No. 7 Limited
    Inventors: Anders Dam, Janos Major, Peter Tasko
  • Publication number: 20130085165
    Abstract: A lozenge is provided that has stable pH and stable levels of active ingredient over time. It comprises a combination of (i) at least one gum and (ii) at least one non-crystallising sugar or non-crystallising sugar alcohol in a matrix designed for controlled buccal delivery of a drug. The lozenge also contains water and optional components selected from flavourings, taste masking agents, colourings, buffer components, pH adjusting agents, excipients, stabilizers and sweeteners. Methods of preparing the lozenge are also provided.
    Type: Application
    Filed: November 26, 2012
    Publication date: April 4, 2013
    Applicant: ARROW NO. 7 LIMITED
    Inventors: Anders Dam, Janos Major, Peter Tasko
  • Publication number: 20120065258
    Abstract: A pharmaceutical composition containing a prostaglandin and an alkanoic acid ester of a polyethoxylated sorbitol in an amount effective to enhance the chemical stability of the prostaglandin, and the use thereof for treating ophthalmic conditions. Also disclosed are methods for enhancing the chemical stability of a prostaglandin-containing composition by using an alkanoic acid ester of a polyethoxylated sorbitol.
    Type: Application
    Filed: November 17, 2011
    Publication date: March 15, 2012
    Inventors: Victor Deaciuc, Michael Hagan, Hashem Heiati, Karen K. Jette, Gary C. Visor, Ian G.C. McAffer, Peter Tasko
  • Patent number: 8084501
    Abstract: A pharmaceutical composition containing a prostaglandin and an alkanoic acid ester of a polyethoxylated sorbitol in an amount effective to enhance the chemical stability of the prostaglandin, and the use thereof for treating ophthalmic conditions. Also disclosed are methods for enhancing the chemical stability of a prostaglandin-containing composition by using an alkanoic acid ester of a polyethoxylated sorbitol.
    Type: Grant
    Filed: January 20, 2006
    Date of Patent: December 27, 2011
    Assignees: Breath Limited, Resolution Chemicals Limited
    Inventors: Victor Deaciuc, Michael Hagan, Hashem Heiati, Karen K. Jette, Gary C. Visor, Ian G. C. McAffer, Peter Tasko
  • Publication number: 20070207091
    Abstract: A sterile nebulizer formulation contains formoterol and budesonide in about 2 ml or less of saline and is for treatment of COPD and asthma and other airways diseases and disorders.
    Type: Application
    Filed: March 1, 2007
    Publication date: September 6, 2007
    Inventors: Ian McAFFER, Peter Tasko
  • Publication number: 20070081949
    Abstract: A lozenge is provided that has stable pH and stable levels of active ingredient over time. It comprises a combination of (i) at least one gum and (ii) at least one non-crystallising sugar or non-crystallising sugar alcohol in a matrix designed for controlled buccal delivery of a drug. The lozenge also contains water and optional components selected from flavourings, taste masking agents, colourings, buffer components, pH adjusting agents, excipients, stabilizers and sweeteners. Methods of preparing the lozenge are also provided.
    Type: Application
    Filed: September 6, 2004
    Publication date: April 12, 2007
    Applicant: Arrow No. 7 Limited
    Inventors: Anders Dam, Janos Major, Peter Tasko
  • Publication number: 20060270735
    Abstract: A pharmaceutical composition containing a prostaglandin and an alkanoic acid ester of a polyethoxylated sorbitol in an amount effective to enhance the chemical stability of the prostaglandin, and the use thereof for treating ophthalmic conditions. Also disclosed are methods for enhancing the chemical stability of a prostaglandin-containing composition by using an alkanoic acid ester of a polyethoxylated sorbitol.
    Type: Application
    Filed: January 20, 2006
    Publication date: November 30, 2006
    Applicant: BREATH LIMITED
    Inventors: Victor Deaciuc, Michael Hagan, Hashem Heiati, Karen Jette, Gary Visor, Ian McAffer, Peter Tasko
  • Publication number: 20060177610
    Abstract: Abstract of the Disclosure An ampoule contains a solution, e.g. an inhalation or injectable pharmaceutical, and an outer surface of the ampoule is coated with a metal or metal compound so as to reduce moisture egress from the ampoule and reduce contamination of ampoule contents from external sources. Labels are easily applied to the coating.
    Type: Application
    Filed: August 4, 2005
    Publication date: August 10, 2006
    Applicant: Arrow International Limited
    Inventors: Ian Gardner McAffer, Peter Tasko
  • Publication number: 20060078505
    Abstract: Methods for administering drugs by nebulisation, together with kits for carrying out the methods, and including components for the production of such kits and unit dose vials.
    Type: Application
    Filed: May 2, 2005
    Publication date: April 13, 2006
    Inventors: Ian McAffer, Peter Tasko